MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3

References

• Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47–52.
   PubMed Web of Science ®Google Scholar
• Kp MA, Turkington RC, Jones C, et al. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846–4861.
   PubMed Web of Science ®Google Scholar
• Hj LY, Sun W, Li S, et al. MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1. Onco Targets Ther. 2015;9:99–109.
   PubMed Web of Science ®Google Scholar
• Kardosh A, Lichtensztajn DY, Gubens MA, et al. Long-term survivors of pancreatic cancer: a California population-based study. Pancreas. 2018;47(8):958–966.
   PubMed Web of Science ®Google Scholar
• Xie H, Ren X, Xin S, et al. Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer. Oncotarget. 2016;7(18):26680–26691.
   PubMed Web of Science ®Google Scholar
• Meng X, Muller V, Milde-Langosch K, et al. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer. Oncotarget. 2016;7(13):16923–16935.
   PubMed Web of Science ®Google Scholar
• Yonemori M, Seki N, Yoshino H, et al. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer. Cancer Sci. 2016;107(9):1233–1242.
   PubMed Web of Science ®Google Scholar
• Li Y, Sarkar FH. MicroRNA targeted therapeutic approach for pancreatic cancer. Int J Biol Sci. 2016;12(3):326–337.
   PubMed Web of Science ®Google Scholar
• Tang S, Wu WK, Li X, et al. Stratification of digestive cancers with different pathological features and survival outcomes by MicroRNA expression. Sci Rep. 2016;6(1):24466.
   PubMedGoogle Scholar
• Chen W, Ye L, Wen D, et al. MiR-490-5p inhibits hepatocellular carcinoma cell proliferation, migration and invasion by directly regulating ROBO1. Pathol Oncol Res. 2019;25(1):1–9.
   PubMed Web of Science ®Google Scholar
• Murphy JE, Wo JY, Ryan DP, et al. Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial. JAMA Oncol. 2018;4(7):963–969.
   PubMed Web of Science ®Google Scholar
• Stein SM, James ES, Deng Y, et al. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. Br J Cancer. 2016;114(7):737–743.
   PubMed Web of Science ®Google Scholar
• Steindorf K, Clauss D, Tjaden C, et al. Quality of life, fatigue, and sleep problems in pancreatic cancer patients—A randomized trial on the effects of exercise. Dtsch Arztebl Int. 2019;116(27–28):471–478.
   PubMed Web of Science ®Google Scholar
• Am AM, Verbeke CS, Gladhaug IP., et al. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells. BMC Cancer. 2019;19(1):596.
   PubMedGoogle Scholar
• Jd LY, Sun J. Tumor suppressive role of miR-33a-5p in pancreatic ductal adenocarcinoma cells by directly targeting RAP2A. Cell Mol Biol Lett. 2021;26(1):24.
   PubMed Web of Science ®Google Scholar
• Yang Z, Li K, Liang Q, et al. Elevated hydrostatic pressure promotes ameloblastoma cell invasion through upregulation of MMP-2 and MMP-9 expression via Wnt/beta-catenin signalling. J Oral Pathol Med. 2018;47(9):836–846.
   PubMed Web of Science ®Google Scholar
• Liu Q, Liu S, Wang X, et al. LncRNA MAGI2-AS3 is involved in cervical squamous cell carcinoma development through CDK6 up-regulation. Infect Agent Cancer. 2019;14(1):37.
   PubMed Web of Science ®Google Scholar
• Wj LC, Zhao L, He H, et al. Knockdown of thymidine kinase 1 suppresses cell proliferation, invasion, migration, and epithelial-mesenchymal transition in thyroid carcinoma cells. Front Oncol. 2020;9:1475.
   PubMed Web of Science ®Google Scholar
• Abdeyrim A, Cheng X, Lian M, et al. miR‑490‑5p regulates the proliferation, migration, invasion and epithelial‑mesenchymal transition of pharyngolaryngeal cancer cells by targeting mitogen‑activated protein kinase kinasekinase 9. Int J Mol Med. 2019;44(1):240–252.
   PubMed Web of Science ®Google Scholar
• Kanno S, Nosho K, Ishigami K, et al. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer. Carcinogenesis. 2017;38(4):425–431.
   PubMed Web of Science ®Google Scholar
• Amponsah PS, Fan P, Bauer N, et al. microRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer. Cancer Lett. 2017;388:107–117.
   PubMed Web of Science ®Google Scholar
• Fan P, Liu L, Yin Y, et al. MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. Cancer Lett. 2016;373(1):130–137.
   PubMed Web of Science ®Google Scholar
• Chijiiwa Y, Moriyama T, Ohuchida K, et al. Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL. Int J Oncol. 2016;48(4):1688–1700.
   PubMed Web of Science ®Google Scholar
• Zhou X, Huang Z, Xu L, et al. A panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancer. Oncotarget. 2016;7(43):69616–69624.
   PubMedGoogle Scholar
• Xiang M, Yuan W, Zhang W, et al. Expression of miR-490-5p, miR-148a-3p and miR-608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells. Oncol Lett. 2019;17(5):4437–4442.
   PubMed Web of Science ®Google Scholar
• Li D, Wang J, Zhang M, et al. LncRNA MAGI2-AS3 is regulated by BRD4 and promotes gastric cancer progression via maintaining ZEB1 overexpression by sponging miR-141/200a. Mol Ther Nucleic Acids. 2020;19:109–123.
   PubMedGoogle Scholar
• Hao XZ, Yang K. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis. Eur Rev Med Pharmacol Sci. 2019;23(17):7399–7407.
   PubMed Web of Science ®Google Scholar
• Aiello NM, Brabletz T, Kang Y, et al. Upholding a role for EMT in pancreatic cancer metastasis. Nature. 2017;547(7661):E7–e8.
   PubMed Web of Science ®Google Scholar
• Fz WJ, Yang J, Yang J, et al. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway. Bioengineered. 2021;12(1):3566–3577.
   PubMed Web of Science ®Google Scholar
• Zh WY, Zhou H. Circular RNA circ_0062389 modulates papillary thyroid carcinoma progression via the miR-1179/high mobility group box 1 axis. Bioengineered. 2021;12(1):1484–1494.
   PubMed Web of Science ®Google Scholar
• Raoof S, Mulford IJ, Frisco-Cabanos H, et al. Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer. Oncogene. 2019;38(37):6399–6413.
   PubMed Web of Science ®Google Scholar
• Vu T, Datta PK. Regulation of EMT in colorectal cancer: a culprit in metastasis. Cancers (Basel). 2017;92 :171.
   PubMedGoogle Scholar
• Islam SS, Mokhtari RB, Noman AS, et al. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer. Mol Carcinog. 2016;55(5):537–551.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang B, Xie J, et al. Melatonin inhibits epithelial to mesenchymal transition in gastric cancer cells via attenuation of IL1beta/NFkappaB/MMP2/MMP9 signaling. Int J Mol Med. 2018;42(4):2221–2228.
   PubMed Web of Science ®Google Scholar
• Yang F, Yu N, Wang H, et al. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9. PloS One. 2018;13(1):e0190725.
   PubMed Web of Science ®Google Scholar
• Lin L, Cheng K, He Z, et al. A polysaccharide from hedyotis diffusa interrupts metastatic potential of lung adenocarcinoma A549 cells by inhibiting EMT via EGFR/Akt/ERK signaling pathways. Int J Biol Macromol. 2019;129:706–714.
   PubMed Web of Science ®Google Scholar
• Cao J, Liu J, Long J, et al. microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2. Biomed Pharmacothe. 2017;89:642–650.
   PubMed Web of Science ®Google Scholar
• Feng YG, Zhao JF, Xiao L, et al. MicroRNA-19a-3p suppresses invasion and metastasis of prostate cancer via inhibiting SOX4. Eur Rev Med Pharmacol Sci. 2018;22(19):6245–6251.
   PubMed Web of Science ®Google Scholar
• Zuo J, Wen J, Lei M, et al. Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT. Med Oncol. 2016;33(2):15.
   PubMed Web of Science ®Google Scholar